<!DOCTYPE html>
<html>
<head>
    <title>In&#xAD;done&#xAD;sia starts na&#xAD;tion&#xAD;wide dis&#xAD;tri&#xAD;bu&#xAD;tion of Si&#xAD;no&#xAD;vac vaccine - PressReader</title>
    <meta name="description" content="It plans to in&#xAD;oc&#xAD;u&#xAD;late 181.5 mil&#xAD;lion peo&#xAD;ple, or 67% of its pop&#xAD;u&#xAD;la&#xAD;tion, within 15 months">
    <meta content="magazines, newspapers, digital news, reading, news, breaking news, newspaper online" name="keywords">
    <meta name="Robots" content="NOARCHIVE,NOODP">
    <meta charset="UTF-8">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    
    <link rel="canonical" href="/singapore/the-straits-times/20210104/281646782763163" />


    <style>
        li {
            margin: 1em 0;
        }
        img {
            max-width: 100%;
        }
        p, h1, h2, h3 {
            max-width: 100%;
        }
    </style>
</head>
<body>
    <div>
        

<article>
    <h1>In&#xAD;done&#xAD;sia starts na&#xAD;tion&#xAD;wide dis&#xAD;tri&#xAD;bu&#xAD;tion of Si&#xAD;no&#xAD;vac vaccine</h1>
    <h2>It plans to in&#xAD;oc&#xAD;u&#xAD;late 181.5 mil&#xAD;lion peo&#xAD;ple, or 67% of its pop&#xAD;u&#xAD;la&#xAD;tion, within 15 months</h2>
    <section>
        <a href="/singapore/the-straits-times/textview" title="The Straits Times">The Straits Times</a>
        - <a href="/singapore/the-straits-times/20210104/textview" title="The Straits Times - 2021-01-04"><time>2021-01-04</time></a>
        - <span>THE BIG STORY</span>
        - <span role="byline">Linda Yulis&#xAD;man&#xD;&#xA;In&#xAD;done&#xAD;sia Cor&#xAD;re&#xAD;spon&#xAD;dent In Jakarta ylinda@sph.com.sg</span>
    </section>

    <p>Na­tion­wide dis­tri­bu­tion of a Covid-19 vaccine de­vel­oped by Chi­nese firm Si­no­vac Biotech be­gan yes­ter­day in In­done­sia.</p>
    <p>Mass in­oc­u­la­tions are sched­uled to be­gin later this month.</p>
    <p>The dis­tri­bu­tion ex­er­cise comes af­ter state vaccine pro­ducer Bio Farma re­ceived 1.2 mil­lion doses of the vaccine on Dec 6 and 1.8 mil­lion doses last Thurs­day.</p>
    <p>Bio Farma be­gan dis­tribut­ing the Si­no­vac vaccine to health fa­cil­i­ties across the coun­try’s 34 prov­inces yes­ter­day, said the com­pany’s Covid-19 vac­ci­na­tion spokesman Bam­bang Heriyanto.</p>
    <p>He added that the storage fa­cil­i­ties nec­es­sary for keep­ing the vaccine doses have been pre­pared.</p>
    <p>“All (vaccine) cold chain fa­cil­i­ties at be­tween 2 deg and 8 deg C are ready. Hope­fully, that will help en­sure the qual­ity of the vac­cines that will be used for the peo­ple,” he told a press brief­ing.</p>
    <p>Mr Bam­bang said In­done­sia has car­ried out a num­ber of na­tional vac­ci­na­tion pro­grammes in the past, so in­fra­struc­ture would not be an is­sue.</p>
    <p>In­done­sia, cur­rently strug­gling to con­trol South-east Asia’s worst coro­n­avirus out­break, plans to in­oc­u­late 181.5 mil­lion peo­ple aged 18 and above, or around 67 per cent of its nearly 270 mil­lion peo­ple, within 15 months.</p>
    <p>The shots will first be given to its 1.3 mil­lion health work­ers, fol­lowed by an­other 17.4 mil­lion front-line work­ers. A to­tal of 21.5 mil­lion peo­ple aged 60 and older will get the j ab be­tween this month and April.</p>
    <p>In the sec­ond phase, sched­uled to run from April this year to March next year, 63.9 mil­lion peo­ple in high-risk ar­eas will get vac­ci­nated, fol­lowed by the re­main­ing 77.4 mil­lion of the tar­geted pop­u­la­tion.</p>
    <p>Speak­ing at the same press brief­ing, the Health Min­istry’s Covid-19 vac­ci­na­tion spokesman, Dr Siti Na­dia Tarmizi, said clin­i­cal tri­als of the Si­no­vac vaccine in Tur­key and Brazil de­liv­ered “quite good” re­sults, same as the on­go­ing third phase of the clin­i­cal trial in In­done­sia.</p>
    <p>The lat­ter paved the way for the na­tional vac­ci­na­tion pro­gramme to run as sched­uled.</p>
    <p>“We are quite op­ti­mistic that (the pro­gramme) will go in line with our sched­ule, and we can be­gin vac­ci­na­tions in the sec­ond or third week of Jan­uary 2021,” Dr Na­dia said.</p>
    <p>In­terim data from a late-stage trial in Tur­key showed that the Si­no­vac vaccine is 91.2 per cent ef­fec­tive, while a sim­i­lar trial in Brazil re­vealed that the shot was more than 50 per cent ef­fec­tive.</p>
    <p>In­done­sia’s vac­ci­na­tion pro­gramme is sub­ject to ap­proval from In­done­sian drug mon­i­tor­ing agency BPOM, which is set to grant emer­gency-use au­tho­ri­sa­tion for the Si­no­vac vaccine to be used.</p>
    <p>Dr Na­dia said the pro­gramme will be car­ried out by around 2,500 hos­pi­tals, 13,000 health com­mu­nity cen­tres and 49 port health au­thor­i­ties across the coun­try. It will be sup­ported by about 30,000 vaccinator­s.</p>
    <p>In­done­sia has so far se­cured nearly 330 mil­lion doses from five dif­fer­ent sup­pli­ers, in­clud­ing Si­no­vac, As­traZeneca and No­vavax, with the pos­si­bil­ity of procur­ing mil­lions more from them if needed.</p>
    <p>The world’s fourth-most pop­u­lous na­tion has re­ported 765,350 Covid-19 in­fec­tions and 22,734 deaths as at yes­ter­day.</p>
    <p>Its pos­i­tiv­ity rate – the pro­por­tion of tests that come back pos­i­tive – is around 30 per cent, much higher than the World Health Or­gan­i­sa­tion’s rec­om­mended rate of 5 per cent or lower – a gen­eral bench­mark for ad­e­quate test­ing.</p>

    <div>
        <picture>
            <img src="https://i.prcdn.co/img?regionKey=vw8og7lVki%2f3dQHPR6%2fNAA%3d%3d" />
        </picture>
        <span role="byline">PHOTO: BLOOMBERG</span>
        <p data-role="text">Re&#xAD;frig&#xAD;er&#xAD;ated ship&#xAD;ping con&#xAD;tain&#xAD;ers with the Si&#xAD;no&#xAD;vac Covid-19 vaccine ar&#xAD;riv&#xAD;ing at Bio Farma&#x2019;s of&#xAD;fices in Ban&#xAD;dung,&#xD;&#xA;West Java, last Thurs&#xAD;day. In&#xAD;done&#xAD;sia has so far se&#xAD;cured nearly&#xD;&#xA;330 mil&#xAD;lion doses of vac&#xAD;cines from five sup&#xAD;pli&#xAD;ers, in&#xAD;clud&#xAD;ing Si&#xAD;no&#xAD;vac, As&#xAD;traZeneca and No&#xAD;vavax.</p>
    </div>

</article>

<section>
    <h3><a href="/catalog/language/english">Newspapers in English</a></h3>
    <h3><a href="/catalog/country/singapore">Newspapers from Singapore</a></h3>
</section>

    </div>
    
    <p><a href="http://www.pressreader.com">© PressReader. All rights reserved.</a></p>

        <script>
            (function (i, s, o, g, r, a, m) {
                i['GoogleAnalyticsObject'] = r; i[r] = i[r] || function () {
                    (i[r].q = i[r].q || []).push(arguments);
                }, i[r].l = 1 * new Date();
                a = s.createElement(o), m = s.getElementsByTagName(o)[0]; a.async = 1; a.src = g;
                m.parentNode.insertBefore(a, m);
            })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
        </script>
        <script>
            ga('create', 'UA-44408245-1');
            ga('send', 'pageView');
        </script>
</body>
</html>
